Quarterly report pursuant to Section 13 or 15(d)

Inventories, net (Tables)

v3.22.2.2
Inventories, net (Tables)
3 Months Ended
Aug. 31, 2022
Inventories, net  
Summary of Inventories, net of reserves

Inventories were as follows (in thousands):

​

​

​

​

​

​

​

​

​

August 31, 2022

​

May 31, 2022

Raw materials

​

$

16,264

​

$

16,264

Work-in-progress

​

 

1,665

​

 

1,665

Total inventories, net

​

$

17,929

​

$

17,929

Schedule of remaining shelf life of inventory

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Raw Materials

​

​

Work-in-progress

​

​

​

(in thousands, Expiration period ending August 31,)

    

Remaining shelf-life (mos)

    

Specialized

​

Resins

​

Other

​

Total Raw Materials

​

Bulk drug product

​

Finished drug product

​

Total inventories

2023

​

0 to 12

$

3,658

$

-

$

1,421

$

5,079

​

$

1,824

​

$

-

​

$

6,903

2024

​

13 to 24

​

682

​

16,264

​

1,590

​

18,536

​

​

1,665

​

​

-

​

​

20,201

2025

​

25 to 36

​

2,099

​

-

​

-

​

2,099

​

​

-

​

​

29,142

​

​

31,241

2026

​

37 to 48

​

3,435

​

-

​

-

​

3,435

​

​

-

​

​

32,344

​

​

35,779

Thereafter

​

49 or more

​

-

​

-

​

-

​

-

​

​

-

​

​

-

​

​

-

Inventories, gross

​

​

​

9,874

​

16,264

​

3,011

​

29,149

​

​

3,489

​

​

61,486

​

​

94,124

Inventory charge

​

​

​

(9,874)

​

-

​

(3,011)

​

(12,885)

​

​

(1,824)

​

​

(61,486)

​

​

(76,195)

Inventories, net

​

​

$

-

$

16,264

$

-

$

16,264

​

$

1,665

​

$

-

​

$

17,929